Dr. Janet Renee Kueker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 43 Thicket Ln, South Beloit, IL 61080 Phone: 815-218-1573 |
News Archive
Results of the landmark RE-LY(R) Trial (Randomized Evaluation of Long term anticoagulant therapy) demonstrate that atrial fibrillation (AF) patients taking PRADAX(R) (dabigatran etexilate) 150mg twice daily (BID) significantly reduced their risk of stroke and systemic embolism by 34 per cent (p less than 0.001) as compared to patients well-controlled on warfarin, without increasing the risk of major bleeding.
City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.
Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, is building working models of human bone, breast, liver and artery tissues to see how cells behave when they are affected by a disease such as cancer.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it will present pre-clinical data on its anticancer compound RX-8243 at the American Association for Cancer Research (AACR) 101st Annual Meeting, held in Washington, D.C., April 17-21, 2010, at the Walter E. Washington Convention Center.
In this post in GlobalPost's "Global Pulse" blog, Katherine Record, a senior fellow at Harvard Law School's Center for Health Law and Policy Innovation, explains "[w]hy the wall between the scientific advancements in AIDS treatment and the treatment itself needs to be broken down in order to truly achieve an 'AIDS-free generation.'"
› Verified 6 days ago